City

Clinical trials near Seattle, United States

Active studies with a listed research site in Seattle, United States.

24active studies

14recruiting now

9countries represented

43largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

HealthyTogether: RCT of a Dyadic Weight Management Intervention

Obesity, OverweightCondition

HealthyTogetherTreatment

United States2 locations

VA Office of Research and DevelopmentSponsor

Updated 2026-09-01 · NCT06619041See eligibility →

Recruiting nowNot applicable

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Chronic Obstructive Pulmonary Disease, Obstructive Sleep ApneaCondition

FOCuSEd Integrated Intervention, Enhanced Usual CareTreatment

United States5 locations

Seattle Institute for Biomedical and Clinical ResearchSponsor

Updated 2026-07-22 · NCT06390345See eligibility →

Recruiting nowPhase 2

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Diabetic Kidney Disease, Type 1 DiabetesCondition

Semaglutide, PlaceboTreatment

Canada, United States4 locations

University of WashingtonSponsor

Updated 2026-06-02 · NCT05822609See eligibility →

Recruiting nowNot applicable

Brain and Behavior Influences on Obesity Development From Infancy Through Childhood

Obesity and OverweightCondition

fMRI cue reactivity task, fMRI go no go taskTreatment

United States4 locations

Johns Hopkins UniversitySponsor

Updated 2026-05-07 · NCT06861868See eligibility →

Recruiting nowNot applicable

Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial

PTSD, ObesityCondition

HARPP, control arm for HARPP trialTreatment

United States1 locations

VA Office of Research and DevelopmentSponsor

Updated 2026-03-18 · NCT07010757See eligibility →

Recruiting nowPhase 3

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

Diabetes Mellitus, Type 1Condition

Semaglutide Pen Injector, PlaceboTreatment

United States2 locations

University of Colorado, DenverSponsor

Updated 2026-03-04 · NCT05819138See eligibility →

Recruiting nowPhase 3

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

Hypothalamic Obesity, Multiple Pituitary Hormone Deficiency Genetic FormCondition

Setmelanotide, PlaceboTreatment

United Kingdom, United States11 locations

Rhythm Pharmaceuticals, Inc.Sponsor

Updated 2026-02-12 · NCT06760546See eligibility →

Recruiting nowPhase 4

Tirzepatide in PWS, HO and GNSO

Prader-Willi Syndrome, Hypothalamic ObesityCondition

TirzepatideTreatment

United States3 locations

Grace KimSponsor

Updated 2025-09-16 · NCT06901245See eligibility →

Recruiting nowNot applicable

ADAPT Study: Assessing Diet, Appetite and Physiology Throughout Weight Loss Study)

ObesityCondition

Behavioral Weight Loss ProgramTreatment

United States2 locations

University of WashingtonSponsor

Updated 2025-08-29 · NCT06174389See eligibility →

Recruiting nowPhase 2

Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

Hypothalamic Obesity, Hypothalamic TumorCondition

Phentermine / Topiramate Extended Release Oral Capsule [Qsymia], PlaceboTreatment

United States2 locations

Seattle Children's HospitalSponsor

Updated 2025-07-28 · NCT06299891See eligibility →

Recruiting nowNot applicable

Building Research for Intervention Development in Gliosis and Eating Habits

Gliosis, Child ObesityCondition

Diet modificationTreatment

United States1 locations

University of WashingtonSponsor

Updated 2025-06-06 · NCT06870578See eligibility →

Recruiting nowNot applicable

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Type 2 Diabetes Mellitus, Diabetic Kidney DiseaseCondition

Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/MLTreatment

United States2 locations

Petter BjornstadSponsor

Updated 2025-03-24 · NCT05008276See eligibility →

Recruiting nowNot applicable

Wakaya: Rising Up for Choctaw Youth Health

Obesity, Adolescent, Healthy NutritionCondition

Wakaya: Rising Up for Choctaw Youth CurriculumTreatment

United States2 locations

University of WashingtonSponsor

Updated 2025-02-20 · NCT05818384See eligibility →

Recruiting nowPhase 4

Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

Diabetes Mellitus, Type 2, Stroke (CVA) or Transient Ischemic AttackCondition

Semaglutide Auto-Injector, PlaceboTreatment

United States1 locations

University of WashingtonSponsor

Updated 2024-06-05 · NCT05780905See eligibility →

Opening soonPhase 3

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Overweight, ObesityCondition

Zenagamtide, SemaglutideTreatment

United States43 locations

Novo Nordisk A/SSponsor

Updated 2026-08-25 · NCT07668414See eligibility →

Opening soonNot applicable

Improving Health Among Disadvantaged Girls to Slow Pubertal Onset and Reduce Long-term Health Risks

Overweight/Obesity, PubertyCondition

Family-Based Treatment (FBT)Treatment

United States1 locations

University of WashingtonSponsor

Updated 2026-03-10 · NCT07460544See eligibility →

Opening soonNot applicable

Inherited and Environmental Risks Acting on Body Weight

Genetics, ObesityCondition

Diet modificationTreatment

United States1 locations

University of WashingtonSponsor

Updated 2026-02-24 · NCT07430852See eligibility →

Active, not recruitingPhase 2

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Obesity & Overweight, Mobility DisabilityCondition

Enobosarm, Semaglutide (Wegovy) weekly injectionTreatment

United States13 locations

Veru Inc.Sponsor

Updated 2026-09-04 · NCT07446998See eligibility →

Active, not recruitingPhase 3

A Trial of Setmelanotide in Acquired Hypothalamic Obesity

Hypothalamic ObesityCondition

Setmelanotide, PlaceboTreatment

Canada, Germany28 locations

Rhythm Pharmaceuticals, Inc.Sponsor

Updated 2026-08-10 · NCT05774756See eligibility →

Active, not recruitingPhase 2

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Overweight, ObesityCondition

Tirzepatide, PlaceboTreatment

Austria, Canada27 locations

Eli Lilly and CompanySponsor

Updated 2026-05-08 · NCT05536804See eligibility →

Active, not recruitingNot applicable

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

Obesity, Weight Change TrajectoryCondition

Revita Duodenal Mucosal Resurfacing (DMR), ShamTreatment

United States32 locations

Fractyl Health Inc.Sponsor

Updated 2026-03-03 · NCT06484114See eligibility →

Active, not recruitingPhase 3

Brain Activation and Satiety in Children 2

Childhood ObesityCondition

Family Based Behavioral Treatment, Exenatide 2 mg [Bydureon]Treatment

United States1 locations

Seattle Children's HospitalSponsor

Updated 2026-01-05 · NCT04520490See eligibility →

Active, not recruitingPhase 3

Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study

Obesity-Related Malignant NeoplasmCondition

Survey Administration, Telephone-Based InterventionTreatment

United States1 locations

Fred Hutchinson Cancer CenterSponsor

Updated 2025-11-24 · NCT04447313See eligibility →

Active, not recruitingNot applicable

Using Signos mHealth Platform in Adults for Weight Management

Overweight and Obesity, Metabolic SyndromeCondition

Signos System, Standard Lifestyle EducationTreatment

United States5 locations

Signos IncSponsor

Updated 2024-10-08 · NCT06214221See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Seattle, United States

Current studies

Related cities